0001629137-15-000001.txt : 20150105 0001629137-15-000001.hdr.sgml : 20150105 20150105161738 ACCESSION NUMBER: 0001629137-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150105 DATE AS OF CHANGE: 20150105 EFFECTIVENESS DATE: 20150105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc. CENTRAL INDEX KEY: 0001629137 IRS NUMBER: 274825712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-231431 FILM NUMBER: 15505015 BUSINESS ADDRESS: STREET 1: 400 EAST JAMIE COURT, SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650741-7700 MAIL ADDRESS: STREET 1: 400 EAST JAMIE COURT, SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0707 D LIVE 0001629137 Global Blood Therapeutics, Inc. 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 650-741-7700 DELAWARE Global Blood Targeting, Inc. None Corporation true 2011 Ted W. Love 400 East Jamie Court, Suite 101 South San Francisco CA CALIFORNIA 94080 Executive Officer Director John Schembri 400 East Jamie Court, Suite 101 South San Francisco CA CALIFORNIA 94080 Executive Officer Kevin Starr 400 East Jamie Court, Suite 101 South San Francisco CA CALIFORNIA 94080 Director Charles Homcy, M.D. 400 East Jamie Court, Suite 101 South San Francisco CA CALIFORNIA 94080 Director Other Decline to Disclose 06b false 2014-12-22 false true false 0 48000000 48000000 0 false 13 0 0 0 The Issuer will use proceeds for general working capital purposes which includes payments to its executive officers and other employees in the ordinary course of business. false Global Blood Therapeutics, Inc. /s/ Ted W. Love Ted. W. Love President 2015-01-05